Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications
Ended Project Grant Awarded Last action
- Award ID
- R43DK109832
- Recipient
-
Regenerative Medical Solutions Inc. UEI WK5KJPECBBA3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $217,389
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Place of performance
- Chicago, IL 60631, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $217,389 |
Quick answers
Who received award R43DK109832?
R43DK109832 was awarded to Regenerative Medical Solutions Inc. by National Institutes of Health (Department of Health and Human Services) on September 16, 2016.
How much is award R43DK109832 worth?
$217,389 has been obligated on R43DK109832.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award